Filing Flows › Lenz Therapeutics (LENZ) › Product sales, net revenue
Lenz Therapeutics (LENZ) Product sales, net revenue by quarter
Lenz Therapeutics' Product sales, net revenue was $2.6M in Q3 2026 (third quarter 2026), +50% from Q2 2026. Over the last 3 quarters it ranged from $1.7M (Q1 2026) to $2.6M (Q3 2026).
| Quarter | Product sales, net revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.6M | +50% | — |
| Q2 2026 | $1.7M | +5% | — |
| Q1 2026 | $1.7M | — | — |
Q3 2026 at a glance
Lenz Therapeutics, Q3 2026: revenue $3.4M (-73% year over year), operating margin -972.8%, net loss $31.0M, operating cash flow −$22.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lenz Therapeutics' Product sales, net revenue?
Lenz Therapeutics' Product sales, net revenue was $2.6M in Q3 2026 (third quarter 2026), +50% from Q2 2026.
How has Lenz Therapeutics' Product sales, net revenue changed?
Over the last 3 quarters it ranged from $1.7M (Q1 2026) to $2.6M (Q3 2026).